Image

Global Tubeless Insulin Pump Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Upcoming Report
  • Feb 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Medical Devices
  • Upcoming Report
  • Feb 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Tubeless Insulin Pump Market, By Type (Insulin Patch Pump, Traditional Pump), Component (Pod/Patch, Remote, Accessories), Distribution Channel (Hospitals, Pharmacies, E- Commerce), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.

Tubeless Insulin Pump Market

Market Analysis and Insights Global Tubeless Insulin Pump Market

Tubeless insulin pump market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to grow at a CAGR of 24.12% in the above-mentioned forecast period.

The tubeless insulin pump is basically a medical handheld device that aids in controlling the blood glucose level. It includes common component pod/patch, remote and accessories such as batteries, reservoirs and others. These are mainly used so they can decrease the need of regular injections. The different components of these pumps namely pod/patch, remote and accessories such as batteries and reservoirs are widely used across the various end use industries such as the hospitals, pharmacies and e- commerce.

The increasing government funding for the study of various diseases and rising prevalence of obesity are the significant factors responsible for driving the growth of the tubeless insulin pump market in the above-mentioned forecast period in the forecast period of 2022 to 2029. In addition to this, the determinants such as the growing ageing population, and increasing approvals for treatment and devices also heighten the overall growth of the market. The rising awareness about the injuries and infections caused by traditional invasive insulin pumps along with the increasing government initiatives and symposiums to create awareness about efficient diabetes care are projected to boost the overall growth of the market in the forecast period of 2022 to 2029. On the other hand, the high cost of the tubeless insulin pumps obstruct the market’s growth. However, the restraints such as the lack of healthcare services in low-income countries is also estimated to hamper the market’s growth within the above mentioned forecast period.

Furthermore, the factors such as the untapped emerging markets and technological advancement in the insulin pumps are expected to generate profitable opportunities for the market in the forecast period of 2022 to 2029. On the other hand, the unfavorable reimbursement policies have the potential to dampen the growth of the market which is estimated to challenge the market’s growth in the above-mentioned forecast period.

This tubeless insulin pump market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research tubeless insulin pump market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Tubeless Insulin Pump Market Scope and Market Size

Tubeless insulin pump market is segmented on the basis of type, component and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of type, the tubeless insulin pump market is segmented into insulin patch pump and traditional pump.
  • On the basis of component, the tubeless insulin pump market is segmented into pod/patch, remote and accessories such as batteries and reservoirs.
  • On the basis of distribution channel, the tubeless insulin pump market is divided into hospitals, pharmacies and e- commerce.

Tubeless Insulin Pump Market Country Level Analysis

Tubeless insulin pump market is analyzed and market size insights and trends are provided by type, component and distribution channel as referenced above.

The countries covered in the tubeless insulin pump market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to the advancement in diabetic management products and increasing cases of diabetes in the region. Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period owing to the increasing government initiatives to enhance awareness about effective diabetes management in the region within the above mentioned forecast period.

The country section of the tubeless insulin pump market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Tubeless insulin pump market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for tubeless insulin pump market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tubeless insulin pump market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Tubeless Insulin Pump Market Share Analysis

Tubeless insulin pump market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to tubeless insulin pump market.

Some of the major players operating in the tubeless insulin pump market report are Abbott, Insulet Corporation., F. Hoffmann-La Roche Ltd, Debiotech S.A, CeQur Corporation., Terumo Corporation, Tandem Diabetes Care, Inc., Johnson & Johnson Private Limited., Copernicus, Medtronic, Siemens, Koninklijke Philips N.V., B. Braun Melsungen AG, BD, Cardinal Health., Cook., Stryker, Bayer AG, Merck & Co., Inc., GE Healthcare and Medtrum Technologies Inc., among others.


SKU-
Why Choose Us


Frequently Asked Questions